NIH Record

Doug Lowy Presents His Vision During Town Hall Meeting

Press Releases

Near-atomic resolution of protein structure by electron microscopy holds promise for drug discovery

A higher than expected fraction of adolescent osteosarcoma patients carry a gene mutation that is often inherited

Blog

Nanoparticle Generator Slips Chemotherapy Past Cells’ Defenses

High-Magnification Microscopy to Visualize Blood Vessels in Real Time

Opportunities in Cancer Nanotechnology

Video Helps Prepare Cancer Patients to Participate in Clinical Trials

Three New Drugs Approved for Multiple Myeloma

New Drug Shows Promise for Pediatric Neuroblastoma

Antioxidants Accelerate the Growth and Invasiveness of Tumors in Mice

Profile: David Q. Matus

CRISPR: Genome Editing Comes of Age

Persistence of Mutations After Chemotherapy Linked to Poorer Outcomes in Some AML Patients

CPTAC: A Complementary Sibling of TCGA

Gene Therapy Approach for Ovarian Cancer Shows Encouraging Signs in Animal Model

Oncolytic Therapy Shows Benefit for Patients with Melanoma

Next Round of Provocative Questions Announced

Women with Dense Breasts May Not Need Additional Screening

Using Gene Expression to Diagnose Lung Cancer More Accurately

Whole Brain Radiation Worsens Cognitive Decline

Microscopy Advances Open Up New Avenues for Cancer Discovery

An Interview with Dr. Frank McCormick

Solving the RAS Problem: Turning Off a Broken Switch

FDA Approves First Therapy for High-Risk Neuroblastoma

FDA Approves First Immunotherapy for Lung Cancer

Who Will Respond to PD-1 Inhibitors? Study Provides Clues

DNA Minicircles Could Improve Cancer Detection, Study Suggests

FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer

“Flipping the Switch”: An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology Branch

FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer